15 February 2021

Patient Blood Management: new SIdEM webinar

Sorry, this entry is only available in Italian. PharmaNutra al fianco di SIdEM (SocietĂ  Italiana di Emaferesi e Manipolazione Cellulare) […]

09 February 2021

SiderAL® Forte 20 capsules confirmed the best-selling food supplement in Italy

2020 ended positively for Sucrosomial® iron-based products, which thanks to SiderAL® Forte have confirmed their market position. December’s market data*, […]

05 February 2021

Midcap analysis: PharmaNutra stronger than its peers. Assigned a buy rating with TP at 42 euro.

On 5áµ—Ę° February, Midcap produced the “Small Touch” survey highlighting how PharmaNutra is performing more consistently that its peers. As […]

20 January 2021

PharmaNutra partecipa all’Italian Mid Cap Conference 2021

Sorry, this entry is only available in Italian. La terza edizione Italian Mid Cap Conference organizzata da Mediobanca si è […]

20 January 2021

Stanchezza e dolori muscolari: le cause possibili

Le principali cause della stanchezza cronica e dei dolori muscolari diffusi.
22 December 2020

Cetilar® Patch and Cetilar® Tape classified as Class 2A MD

The Higher Institute for Health (ISS) has classified Cetilar® Patch and Cetilar® Tape as Class 2A Medical Devices, while the U.S. […]

15 December 2020

PharmaNutra entra nel mercato MTA – segmento STAR di Borsa Italiana

Sorry, this entry is only available in Italian. Questa mattina hanno avuto inizio sul mercato MTA – segmento STAR di […]

01 December 2020

Partnership with the Zambon Group for the distribution of Sucrosomial® Iron in Brazil

PharmaNutra and Zambon extend their collaboration to introduce two new Sucrosomial® Iron-based products to the Brazilian market.   After the […]

18 November 2020

New international distribution agreement for Greece, Cyprus and Mauritius

The PharmaNutra Group will be present in Greece and Cyprus with its Cetilar® products, while SiderAL® Forte will be distributed […]

11 November 2020

Registration of Cetilar® and SiderAL® trademarks granted in the USA

The American administrative body for patents, USPTO, communicates registration of the figurative and word marks of the two flagship PharmaNutra […]

09 November 2020

Consolidated financial report as at 30th September 2020

PharmaNutra S.p.A. communicates that the Board of Directors has examined and approved the consolidated financial report as at 30th September 2020, […]

04 November 2020

Riparte la campagna ApportAL® “Fatti trovare pronto!”

Sorry, this entry is only available in Italian. PharmaNutra lancia una nuova campagna TV, radio e digital dedicata al complemento […]

1 2 … 38